Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartz

Showing results (961-970 of 1,151) with videos related to

Pageof 116
Sort By:
Cancers|August 12, 2023
Population-Based Clinical Cancer Registration in GermanyAlexander Katalinic, Marco Halber, Martin Meyer, et al.
Environmental Pollution (Barking, Essex : 1987)|September 18, 2025
Development of a fipronil insecticide response spectrum model for juvenile Chinook salmon (Oncorhynchus tshawytscha)Kara E Huff Hartz, Katie J Knaub, Louise Cominassi, et al.
Infection Control and Hospital Epidemiology|May 5, 2016
Media Stories on NICU Outbreaks Lead to an Increased Prescription Rate of Third-Line Antibiotics in the Community of Neonatal CareChristoph Härtel, Annika Hartz, Lina Bahr, et al.
Plos One|April 10, 2015
Preterm prelabor rupture of membranes and outcome of very-low-birth-weight infants in the German Neonatal NetworkKathrin Hanke, Annika Hartz, Maike Manz, et al.
Journal of Medicinal Chemistry|May 14, 2021
Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 InhibitorsLi Xu, Richard A Hartz, Brett R Beno, et al.
Promotion & Education|September 16, 2005
[Integrating prevention and promotion in health systems: four realities, diverse similarities]Josée Bourdages, Yvon Brunelle, Louise St-Pierre, et al.
Journal of Medicinal Chemistry|March 23, 2023
Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-<i>b</i>]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) InhibitorsRichard A Hartz, Vijay T Ahuja, Prasanna Sivaprakasam, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 3, 2022
[Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]Monika Klinkhammer-Schalke, Simone Wesselmann, Johannes Bruns, et al.
Journal of Medicinal Chemistry|November 28, 2022
Synthesis, Structure-Activity Relationships, and <i>In Vivo</i> Evaluation of Novel C-17 Amine Derivatives Based on GSK3640254 as HIV-1 Maturation Inhibitors with Broad Spectrum ActivityRichard A Hartz, Li Xu, Sing-Yuen Sit, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2013
Potential CRF1R PET imaging agents: 1-fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-onesDerek J Denhart, Dmitry Zuev, Jonathan L Ditta, et al.
Pageof 116

Showing results (961-970 of 1,151) with videos related to

Sort By:
Pageof 116
Cancers|August 12, 2023
Population-Based Clinical Cancer Registration in GermanyAlexander Katalinic, Marco Halber, Martin Meyer, et al.
Environmental Pollution (Barking, Essex : 1987)|September 18, 2025
Development of a fipronil insecticide response spectrum model for juvenile Chinook salmon (Oncorhynchus tshawytscha)Kara E Huff Hartz, Katie J Knaub, Louise Cominassi, et al.
Infection Control and Hospital Epidemiology|May 5, 2016
Media Stories on NICU Outbreaks Lead to an Increased Prescription Rate of Third-Line Antibiotics in the Community of Neonatal CareChristoph Härtel, Annika Hartz, Lina Bahr, et al.
Plos One|April 10, 2015
Preterm prelabor rupture of membranes and outcome of very-low-birth-weight infants in the German Neonatal NetworkKathrin Hanke, Annika Hartz, Maike Manz, et al.
Journal of Medicinal Chemistry|May 14, 2021
Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 InhibitorsLi Xu, Richard A Hartz, Brett R Beno, et al.
Promotion & Education|September 16, 2005
[Integrating prevention and promotion in health systems: four realities, diverse similarities]Josée Bourdages, Yvon Brunelle, Louise St-Pierre, et al.
Journal of Medicinal Chemistry|March 23, 2023
Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-<i>b</i>]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) InhibitorsRichard A Hartz, Vijay T Ahuja, Prasanna Sivaprakasam, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 3, 2022
[Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]Monika Klinkhammer-Schalke, Simone Wesselmann, Johannes Bruns, et al.
Journal of Medicinal Chemistry|November 28, 2022
Synthesis, Structure-Activity Relationships, and <i>In Vivo</i> Evaluation of Novel C-17 Amine Derivatives Based on GSK3640254 as HIV-1 Maturation Inhibitors with Broad Spectrum ActivityRichard A Hartz, Li Xu, Sing-Yuen Sit, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2013
Potential CRF1R PET imaging agents: 1-fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-onesDerek J Denhart, Dmitry Zuev, Jonathan L Ditta, et al.
Pageof 116